MedPageToday
MedPage Today) — TORONTO — A quadruplet regimen elicited favorable outcomes in an older population of transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM), according to phase II trial data.
The study of daratumumab…
Read More
Quadruplet Promising in Older Patients With Transplant-Ineligible Multiple Myeloma
Lyndia Schroeder
16:19
MedPage Today) — TORONTO — A quadruplet regimen elicited favorable outcomes in an older population of transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM), according to phase II trial data. The study of daratumumab…
